secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K/A
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001790340-24-000073
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering appoints Dr. Thomas Schall to Compensation Committee effective Oct 1, 2024
--------------------------------------------------------------------------------

- Dr. Thomas Schall appointed to Compensation Committee of Board, effective Oct 1, 2024.
- Previous election as Class I director on March 11, 2024; committee assignment now settled.
- Appointment follows recommendation of Nominating and Corporate Governance Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000179034024000073/0001790340-24-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000179034024000073/imrx-20240311.htm
  HTML page:      https://secwatch.observer/filing/0001790340-24-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer